IRS1 and breast cancer: Our group described PTP-BL role in adipocyte differentiation 10 and reported the first evidence of PTPN13 tumor-suppressive, anti-growth factor effect, via insulin receptor substrate 1 (IRS1) dephosphorylation, in human breast cancer cell lines incubated with anti-estrogens 11-13.